{"resourceType":"Bundle","type":"searchset","entry":[{"resource":{"resourceType":"Parameters","id":"ImmDS-2013-0206","parameter":[{"name":"assessentDate","valueDate":"2020-06-29"},{"name":"patient","resource":{"resourceType":"Patient","id":"2013-0206","name":[{"text":"Dose 1 to dose 3 interval 16 weeks-4 days. Series complete. \nEvaluation_Test_Type: Interval: At Absolute Minimum\nGeneral_Description: This test case describes when dose #3 of the Hep B vaccine is administered at an interval of 16 weeks - 4 days from dose #1 that the dose is considered to be valid.  The series is complete."}],"gender":"female","birthDate":"2019-12-15"}},{"name":"immunization","resource":{"resourceType":"Immunization","id":"2013-0206-dose1","status":"completed","vaccineCode":{"coding":[{"system":"http://hl7.org/fhir/sid/cvx","code":"8","display":"RECOMBIVAX-PEDS"},{"system":"http://hl7.org/fhir/v2/0227","code":"MSD","display":"RECOMBIVAX-PEDS"}]},"patient":{"reference":"Patient/2013-0206"},"occurrenceDateTime":"2020-03-13T00:00:00.000"}},{"name":"immunization","resource":{"resourceType":"Immunization","id":"2013-0206-dose2","status":"completed","vaccineCode":{"coding":[{"system":"http://hl7.org/fhir/sid/cvx","code":"8","display":"RECOMBIVAX-PEDS"},{"system":"http://hl7.org/fhir/v2/0227","code":"MSD","display":"RECOMBIVAX-PEDS"}]},"patient":{"reference":"Patient/2013-0206"},"occurrenceDateTime":"2020-05-06T00:00:00.000"}},{"name":"immunization","resource":{"resourceType":"Immunization","id":"2013-0206-dose3","status":"completed","vaccineCode":{"coding":[{"system":"http://hl7.org/fhir/sid/cvx","code":"8","display":"RECOMBIVAX-PEDS"},{"system":"http://hl7.org/fhir/v2/0227","code":"MSD","display":"RECOMBIVAX-PEDS"}]},"patient":{"reference":"Patient/2013-0206"},"occurrenceDateTime":"2020-06-29T00:00:00.000"}}]},"request":{"method":"PUT","url":"Parameters"}}]}